More patients than ever could be eligible for transplant Traditionally, an arbitrary measure – age – has been the marker of a patient’s eligibility for autologous stem cell transplantation (ASCT).1 Which side of the golden age of 65 a patient was determined their treatment choice – to transplant – or not to transplant. These days, ...
Is 65 the new 55 when it comes to transplant eligibility in multiple myeloma?
30 Nov 2017
Sponsored by Janssen Cilag Pty Ltd